StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) stock

BNRNasdaqServices-Medical Laboratories
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$12.50−0.24 (-1.88%)

Close on Nov 17, 2026Market cap $136.07MP/E –Yield –

Burning Rock Biotech total assets

Total assets on the balance sheet at the end of each period.

Burning Rock Biotech's total assets was CN¥820.38M at Dec 31, 2025. For fiscal 2025 it was CN¥820.38M, down 7.3% from the year before. The highest annual figure on record is CN¥2.66B in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥820.38M-7.3%
FY2024Dec 31, 2024CN¥885.31M-14.9%
FY2023Dec 31, 2023CN¥1.04B-34.5%
FY2022Dec 31, 2022CN¥1.59B-30.3%
FY2021Dec 31, 2021CN¥2.28B-14.4%
FY2020Dec 31, 2020CN¥2.66B+214.2%
FY2019Dec 31, 2019CN¥847.56M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025CN¥820.38M-55.9%
Q4 FY2024Dec 31, 2024CN¥885.31M-61.1%
Q4 FY2023Dec 31, 2023CN¥1.04B-60.9%
Q4 FY2022Dec 31, 2022CN¥1.59B+87.3%
Q2 FY2022Jun 30, 2022CN¥1.86B–
Q4 FY2021Dec 31, 2021CN¥2.28B–
Q4 FY2020Dec 31, 2020CN¥2.66B–
Q4 FY2019Dec 31, 2019CN¥847.56M–

More Burning Rock Biotech figures

See a number that looks wrong?